Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

CBBC's Operation Ouch have been helping to raise awareness of participation in clinical trials for children.

CRAFFT Science

 

CI of the CRAFFT and SCIENCE trials, Daniel Perry, tells us about the team's recent work with CBBC's Operation Ouch!

"Involving individuals in decisions about their treatment is somewhat of an art - requiring information to be delivered to them in a way that is engaging, appropriate and thorough. This is made more difficult when introducing uncertainty, and offering the opportunities to participate in a randomised trial. This is therefore especially difficult when then patient is a child, the disease is an injury, and the treatment is whether or not to have an operation.

The team for the children’s trauma studies CRAFFT and SCIENCE have enlisted some help in communicating the uncertainty - in the form of TV stars from CBBC's Operation Ouch, twins Dr Xand & Dr Chris van Tulleken. Their simple explanation of these trials makes is accessible to everyone - and is a pleasure to watch."

The OCTRU team think the video is excellent - watch on Twitter by clicking here

 

Visit the CRAFFT trial website.

Visit the SCIENCE trial website.

Similar stories

WHiTE Four trial results!

OCTRU

The WHiTE Four trial has now published its results in The Bone & Joint journal.

FUTURE GB Trial opens to recruitment!

OCTRU

The FUTURE GB Trial has received OCTRU Green Light approval and is now open to recruitment!

ARCADIAN trial opens to recruitment!

OCTRU

The ARCADIAN trial has received OCTRU Green Light approval and has now begun to open sites to recruitment!

HOPE-e study resumes recruitment of women with painful osteoarthritis in the hand

Main OCTRU

Researchers in Oxford are looking to recruit women who have painful osteoarthritis in joints of their hands, after resuming a study that was paused due to the COVID crisis.

HUSH trial opens to recruitment!

OCTRU

The HUSH trial has received OCTRU Green Light approval and is now open to recruitment!

Oxford researchers start new trial on the use of anti-TNF to treat Covid-19 in care homes

Main OCTRU Trials

Researchers at the University of Oxford are starting a new study to explore the effectiveness of the anti-tumour necrosis factor (anti-TNF) drug adalimumab as a treatment for patients with COVID-19 in the community, especially care homes. The AVID-CC trial, which will be conducted by Oxford Clinical Trials Research Unit (OCTRU), will enrol up to 750 patients from community care settings throughout the UK.